Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Researchers have found that the glucagon-like peptide-1 analogue liraglutide – a treatment for type 2 diabetes – is also effective in non-alcoholic steatohepatitis (NASH), micrograph pictured

Non-alcoholic steatohepatitis (NASH, micrograph pictured) could be treated with the diabetes drug liraglutide following the success of a small clinical trial

Source  Nephron / Wikimedia Commons